{
     "PMID": "26003667",
     "OWN": "NLM",
     "STAT": "In-Data-Review",
     "LR": "20170817",
     "IS": "0006-3002 (Print) 0006-3002 (Linking)",
     "VI": "1852",
     "IP": "9",
     "DP": "2015 Sep",
     "TI": "High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents.",
     "PG": "1687-99",
     "LID": "10.1016/j.bbadis.2015.05.004 [doi] S0925-4439(15)00147-7 [pii]",
     "AB": "Global obesity is a pandemic status, estimated to affect over 2 billion people, that has resulted in an enormous strain on healthcare systems worldwide. The situation is compounded by the fact that apart from the direct costs associated with overweight pathology, obesity presents itself with a number of comorbidities, including an increased risk for the development of neurodegenerative disorders. Alzheimer disease (AD), the main cause of senile dementia, is no exception. Spectacular failure of the pharmaceutical industry to come up with effective AD treatment strategies is forcing the broader scientific community to rethink the underlying molecular mechanisms leading to cognitive decline. To this end, the emphasis is once again placed on the experimental animal models of the disease. In the current study, we have focused on the effects of a high-fat diet (HFD) on hippocampal-dependent memory in C57/Bl6 Wild-type (WT) and APPswe/PS1dE9 (APP/PS1) mice, a well-established mouse model of familial AD. Our results indicate that the continuous HFD administration starting at the time of weaning is sufficient to produce beta-amyloid-independent, hippocampal-dependent memory deficits measured by a 2-object novel-object recognition test (NOR) in mice as early as 6months of age. Furthermore, the resulting metabolic syndrome appears to have direct effects on brain insulin regulation and mitochondrial function. We have observed pathological changes related to both the proximal and distal insulin signaling pathway in the brains of HFD-fed WT and APP/PS1 mice. These changes are accompanied by a significantly reduced OXPHOS metabolism, suggesting that mitochondria play an important role in hippocampus-dependent memory formation and retention in both the HFD-treated and AD-like rodents at a relatively young age.",
     "CI": [
          "Copyright (c) 2015 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Petrov, Dmitry",
          "Pedros, Ignacio",
          "Artiach, Gonzalo",
          "Sureda, Francesc X",
          "Barroso, Emma",
          "Pallas, Merce",
          "Casadesus, Gemma",
          "Beas-Zarate, Carlos",
          "Carro, Eva",
          "Ferrer, Isidro",
          "Vazquez-Carrera, Manuel",
          "Folch, Jaume",
          "Camins, Antoni"
     ],
     "AU": [
          "Petrov D",
          "Pedros I",
          "Artiach G",
          "Sureda FX",
          "Barroso E",
          "Pallas M",
          "Casadesus G",
          "Beas-Zarate C",
          "Carro E",
          "Ferrer I",
          "Vazquez-Carrera M",
          "Folch J",
          "Camins A"
     ],
     "AD": "Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Institut de Biomedicina de la UB (IBUB), Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Unitats de Bioquimica i Farmacologia, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus (Tarragona), Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Institut de Biomedicina de la UB (IBUB), Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Unitats de Bioquimica i Farmacologia, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus (Tarragona), Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Institut de Biomedicina de la UB (IBUB), Universitat de Barcelona, Barcelona, Spain; Centros de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Spain. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Institut de Biomedicina de la UB (IBUB), Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Department of Biological Sciences Kent State University, Kent, OH, USA. Laboratorio de Neurobiologia Celular y Molecular, Division de Neurociencias, CIBO, IMSS, Mexico; Laboratorio de Regeneracion y Desarrollo Neural, Instituto de Neurobiologia, Departamento de Biologia Celular y Molecular, CUCBA, Mexico. Neuroscience Group, Instituto de Investigacion Hospital 12 de Octubre, Madrid, Spain. Institute of Neuropathology, Bellvitge University Hospital-Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Institut de Biomedicina de la UB (IBUB), Universitat de Barcelona, Barcelona, Spain; Centros de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Spain. Unitats de Bioquimica i Farmacologia, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus (Tarragona), Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Institut de Biomedicina de la UB (IBUB), Universitat de Barcelona, Barcelona, Spain; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Universidad Nacional de Loja, Department of Biotechnology, Ecuador. Electronic address: camins@ub.edu.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20150521",
     "PL": "Netherlands",
     "TA": "Biochim Biophys Acta",
     "JT": "Biochimica et biophysica acta",
     "JID": "0217513",
     "SB": "IM",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "APPSwe/PS1dE9",
          "Alzheimer disease",
          "Hippocampus",
          "Insulin receptor",
          "Mitochondria",
          "TAU"
     ],
     "EDAT": "2015/05/25 06:00",
     "MHDA": "2015/05/25 06:01",
     "CRDT": [
          "2015/05/25 06:00"
     ],
     "PHST": [
          "2015/02/25 00:00 [received]",
          "2015/04/09 00:00 [revised]",
          "2015/05/06 00:00 [accepted]",
          "2015/05/25 06:00 [entrez]",
          "2015/05/25 06:00 [pubmed]",
          "2015/05/25 06:01 [medline]"
     ],
     "AID": [
          "S0925-4439(15)00147-7 [pii]",
          "10.1016/j.bbadis.2015.05.004 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Biochim Biophys Acta. 2015 Sep;1852(9):1687-99. doi: 10.1016/j.bbadis.2015.05.004. Epub 2015 May 21.",
     "term": "hippocampus"
}